{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T21:35:06Z","timestamp":1781127306282,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T00:00:00Z","timestamp":1255564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1245\/s10434-009-0717-9","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T16:35:26Z","timestamp":1255538126000},"page":"3463-3472","source":"Crossref","is-referenced-by-count":33,"title":["Isolated Limb Infusion for Malignant Melanoma: Predictors of Response and Outcome"],"prefix":"10.1245","volume":"16","author":[{"given":"Andrew P.","family":"Barbour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Suffolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Beller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Mark","family":"Smithers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,15]]},"reference":[{"issue":"4","key":"717_CR1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jso.10077","volume":"79","author":"BB Kroon","year":"2002","unstructured":"Kroon BB, Noorda EM, Vrouenraets BC, Nieweg OE. Isolated limb perfusion for melanoma. J Surg Oncol. 2002;79(4):252\u20135.","journal-title":"J Surg Oncol"},{"issue":"2","key":"717_CR2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1245\/aso.2002.9.2.127","volume":"9","author":"P Lindner","year":"2002","unstructured":"Lindner P, Doubrovsky A, Kam PC, Thompson JF. Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma. Ann Surg Oncol. 2002;9(2):127\u201336.","journal-title":"Ann Surg Oncol"},{"issue":"25","key":"717_CR3","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1200\/JCO.2005.05.5152","volume":"24","author":"WR Cornett","year":"2006","unstructured":"Cornett WR, McCall LM, Petersen RP, et al. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol. 2006;24(25):4196\u2013201.","journal-title":"J Clin Oncol"},{"issue":"3","key":"717_CR4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<238::AID-SSU8>3.0.CO;2-9","volume":"14","author":"JF Thompson","year":"1998","unstructured":"Thompson JF, Kam PC, Waugh RC, Harman CR. Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. Semin Surg Oncol. 1998;14(3):238\u201347.","journal-title":"Semin Surg Oncol"},{"issue":"11","key":"717_CR5","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1245\/s10434-008-9954-6","volume":"15","author":"HM Kroon","year":"2008","unstructured":"Kroon HM, Moncrieff M, Kam PC, Thompson JF. Outcomes following isolated limb infusion for melanoma. A 14-year experience. Ann Surg Oncol. 2008;15(11):3003\u201313.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"717_CR6","first-page":"189","volume":"44","author":"R Mian","year":"2001","unstructured":"Mian R, Henderson MA, Speakman D, et al. Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion. Can J Surg. 2001;44(3):189\u201392.","journal-title":"Can J Surg"},{"issue":"8","key":"717_CR7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1245\/ASO.2006.05.003","volume":"13","author":"MS Brady","year":"2006","unstructured":"Brady MS, Brown K, Patel A, et al. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity. Ann Surg Oncol. 2006;13(8):1123\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"717_CR8","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1245\/s10434-008-9988-9","volume":"15","author":"GM Beasley","year":"2008","unstructured":"Beasley GM, Petersen RP, Yoo J, et al. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Ann Surg Oncol. 2008;15(8):2195\u2013205.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"717_CR9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.rlu.0000242602.56590.c5","volume":"31","author":"ER Ryan","year":"2006","unstructured":"Ryan ER, Hill AD, Skehan SJ. FDG PET\/CT demonstrates the effectiveness of isolated limb infusion for malignant melanoma. Clin Nucl Med. 2006;31(11):707\u20138.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"717_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11864-004-0009-3","volume":"5","author":"DL Fraker","year":"2004","unstructured":"Fraker DL. Management of in-transit melanoma of the extremity with isolated limb perfusion. Curr Treat Options Oncol. 2004;5(3):173\u201384.","journal-title":"Curr Treat Options Oncol"},{"key":"717_CR11","doi-asserted-by":"crossref","unstructured":"Kam PC, Thompson JF. Pharmacokinetics of regional therapy: isolated limb infusion and other low flow techniques for extremity melanoma. Surg Oncol Clin North Am. 2008;17(4):795\u2013804, ix.","DOI":"10.1016\/j.soc.2008.04.003"},{"issue":"10","key":"717_CR12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","volume":"18","author":"J Wieberdink","year":"1982","unstructured":"Wieberdink J, Benckhuysen C, Braat RP, et al. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol. 1982;18(10):905\u201310.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"717_CR13","unstructured":"World Health Organization. Geneva: World Health Organization. WHO Handbook for Reporting Results of Cancer Treatments (WHO Offset Publication No. 48)."},{"key":"717_CR14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2307\/2529881","volume":"38","author":"RSD Miller","year":"1982","unstructured":"Miller RSD. Maximally selected chi-square statistics. Biometrics. 1982;38:1011\u20131016.","journal-title":"Biometrics"},{"issue":"11","key":"717_CR15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archsurg.140.11.1115","volume":"140","author":"TA Aloia","year":"2005","unstructured":"Aloia TA, Grubbs E, Onaitis M, et al. Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response. Arch Surg. 2005;140(11):1115\u201320.","journal-title":"Arch Surg"},{"issue":"11","key":"717_CR16","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1097-0142(19850601)55:11<2638::AID-CNCR2820551118>3.0.CO;2-E","volume":"55","author":"DR Minor","year":"1985","unstructured":"Minor DR, Allen RE, Alberts D, et al. A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma. Cancer. 1985;55(11):2638\u201344.","journal-title":"Cancer"},{"issue":"12","key":"717_CR17","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/1097-0142(19890615)63:12<2551::AID-CNCR2820631233>3.0.CO;2-7","volume":"63","author":"F Di Filippo","year":"1989","unstructured":"Di Filippo F, Calabro A, Giannarelli D, et al. Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer. 1989;63(12):2551\u201361.","journal-title":"Cancer"},{"issue":"1","key":"717_CR18","first-page":"39","volume":"115","author":"JM Klaase","year":"1994","unstructured":"Klaase JM, Kroon BB, van Geel AN, et al. Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery. 1994;115(1):39\u201345.","journal-title":"Surgery"},{"issue":"7","key":"717_CR19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/bjs.1800770716","volume":"77","author":"AI Skene","year":"1990","unstructured":"Skene AI, Bulman AS, Williams TR, et al. Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb. Br J Surg. 1990;77(7):765\u20137.","journal-title":"Br J Surg"},{"issue":"5","key":"717_CR20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jamcollsurg.2008.12.019","volume":"208","author":"GM Beasley","year":"2009","unstructured":"Beasley GM, Caudle A, Petersen RP, et al. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg. 2009;208(5):706\u201315; discussion 715\u20137.","journal-title":"J Am Coll Surg"},{"issue":"17","key":"717_CR21","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1158\/1078-0432.CCR-04-0096","volume":"10","author":"OI Abdel-Wahab","year":"2004","unstructured":"Abdel-Wahab OI, Grubbs E, Viglianti BL, et al. The role of hyperthermia in regional alkylating agent chemotherapy. Clin Cancer Res. 2004;10(17):5919\u201329.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"717_CR22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0360-3016(91)90106-E","volume":"20","author":"DW Siemann","year":"1991","unstructured":"Siemann DW, Chapman M, Beikirch A. Effects of oxygenation and pH on tumor cell response to alkylating chemotherapy. Int J Radiat Oncol Biol Phys. 1991;20(2):287\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"717_CR23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/bjc.1994.266","volume":"70","author":"JM Klaase","year":"1994","unstructured":"Klaase JM, Kroon BB, Beijnen JH, et al. Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb. Br J Cancer. 1994;70(1):151\u20133.","journal-title":"Br J Cancer"},{"issue":"10","key":"717_CR24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10434-001-0771-4","volume":"8","author":"TG Zogakis","year":"2001","unstructured":"Zogakis TG, Bartlett DL, Libutti SK, et al. Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma. Ann Surg Oncol. 2001;8(10):771\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"717_CR25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.sla.0000251746.02764.fc","volume":"245","author":"A Sanki","year":"2007","unstructured":"Sanki A, Kam PC, Thompson JF. Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology. Ann Surg. 2007;245(4):591\u20136.","journal-title":"Ann Surg"},{"issue":"3","key":"717_CR26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejso.2005.10.009","volume":"32","author":"EM Noorda","year":"2006","unstructured":"Noorda EM, Vrouenraets BC, Nieweg OE, et al. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion. Eur J Surg Oncol. 2006;32(3):318\u201324.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"717_CR27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0959-8049(05)80163-7","volume":"29A","author":"FJ Lejeune","year":"1993","unstructured":"Lejeune FJ, Lienard D, Leyvraz S, Mirimanoff RO. Regional therapy of melanoma. Eur J Cancer. 1993;29A(4):606\u201312.","journal-title":"Eur J Cancer"},{"key":"717_CR28","doi-asserted-by":"crossref","unstructured":"Kroon HM, Moncrieff M, Kam PC, Thompson JF. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients. Ann Surg Oncol. 2009: ahead of print.","DOI":"10.1245\/s10434-009-0323-x"},{"issue":"16","key":"717_CR29","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635\u201348.","journal-title":"J Clin Oncol"},{"key":"717_CR30","doi-asserted-by":"crossref","unstructured":"Kroon BB, Noorda EM, Vrouenraets BC, et al. Isolated limb perfusion for melanoma. Surg Oncol Clin North Am. 2008;17(4):785\u201394, viii\u2013ix.","DOI":"10.1016\/j.soc.2008.04.005"},{"issue":"1","key":"717_CR31","first-page":"1","volume":"169","author":"DP Jaques","year":"1989","unstructured":"Jaques DP, Coit DG, Brennan MF. Major amputation for advanced malignant melanoma. Surg Gynecol Obstet. 1989;169(1):1\u20136.","journal-title":"Surg Gynecol Obstet"},{"key":"717_CR32","doi-asserted-by":"crossref","unstructured":"Santillan AA, Delman KA, Beasley GM, et al. Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis. Ann Surg Oncol. 2009 [Ahead of print]","DOI":"10.1245\/s10434-009-0563-9"},{"issue":"4","key":"717_CR33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1245\/s10434-008-0288-1","volume":"16","author":"N McMahon","year":"2009","unstructured":"McMahon N, Cheng TY, Beasley GM, et al. Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity? Ann Surg Oncol. 2009;16(4):953\u201361.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"717_CR34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1054\/bjoc.2001.1902","volume":"85","author":"JF Thompson","year":"2001","unstructured":"Thompson JF, Siebert GA, Anissimov YG, et al. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies. Br J Cancer. 2001;85(2):157\u201365.","journal-title":"Br J Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-009-0717-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0717-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:35:11Z","timestamp":1572971711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-009-0717-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,15]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1245\/s10434-009-0717-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,15]]}}}